Form D — Abingworth Clinical Co-Development Fund 3 LP
0002049495-25-000001 · filed Jun 25, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Reported offering amount
- —
- Reported amount sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Abingworth Clinical Co-Development Fund 3 LP
- CIK
- 2049495
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 1001 PENNSYLVANIA AVENUE, NW
WASHINGTON, District of Columbia 20004 - Phone
- 202-729-5626
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A ACCD 3 GP LP · PromoterWashington, District of Columbia Find on LinkedIn ↗
-
N/A ACCD 3 Holdings, L.L.C. · PromoterWashington, District of Columbia Find on LinkedIn ↗
-
David Lobe · Executive OfficerWashington, District of Columbia Find on LinkedIn ↗
-
Jeremy Anderson · Executive OfficerWashington, District of Columbia Find on LinkedIn ↗
-
Robert Rosen · Executive OfficerWashington, District of Columbia Find on LinkedIn ↗
-
Christina Gibbs · Executive OfficerWashington, District of Columbia Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗